Group 1 - The Hang Seng Healthcare Index (HSHCI) increased by 0.54%, with notable gains from companies such as Micron Brain Science (4.73%) and Boan Biotechnology (4.50%) [3] - The Hang Seng Healthcare ETF (513060) rose by 0.42%, with a latest price of 0.48 yuan and a turnover rate of 1.92% [3] - The average daily trading volume of the Hang Seng Healthcare ETF over the past month was 1.748 billion yuan, ranking it first among comparable funds [3] Group 2 - The DeepSeek R1 model has been adopted by multiple pharmaceutical companies, enhancing AI applications in healthcare, particularly in areas like retinal imaging and infectious disease management [4] - The Hang Seng Healthcare ETF closely tracks the Hang Seng Healthcare Index, which reflects the overall performance of healthcare securities listed in Hong Kong [4] - The latest size of the Hang Seng Healthcare ETF reached 9.964 billion yuan, placing it in the top third among comparable funds [4] Group 3 - The Hang Seng Healthcare ETF has shown a net value increase of 26.52% over the past year, with a maximum monthly return of 28.34% since inception [5] - The ETF's management fee is 0.50%, and the custody fee is 0.15% [5] - The tracking error of the Hang Seng Healthcare ETF is 0.041%, the highest precision among comparable funds [5] Group 4 - The current price-to-earnings ratio (PE-TTM) of the Hang Seng Healthcare Index is 24.24, indicating a valuation lower than 94.91% of the time over the past year [5] - The top ten weighted stocks in the Hang Seng Healthcare Index account for 56.7% of the index, with notable companies including WuXi Biologics and BeiGene [5][7]
AI+医疗有望加速落地，恒生医疗ETF(513060)反弹上涨，微创脑科学领涨